Polar Capital Holdings’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145M | Buy |
837,777
+312,777
| +60% | +$54M | 0.76% | 40 |
|
|
2025
Q1 | $81.8M | Buy |
525,000
+225,000
| +75% | +$35.1M | 0.5% | 55 |
|
|
2024
Q4 | $41.3M | Buy |
300,000
+75,000
| +33% | +$10.3M | 0.23% | 110 |
|
|
2024
Q3 | $33.6M | Buy |
+225,000
| New | +$33.6M | 0.16% | 112 |
|
|
2021
Q2 | – | Sell |
-2,524
| Closed | -$325K | – | 352 |
|
|
2021
Q1 | $325K | Sell |
2,524
-50,000
| -95% | -$6.44M | ﹤0.01% | 310 |
|
|
2020
Q4 | $8.76M | Buy |
+52,524
| New | +$8.76M | 0.05% | 217 |
|